Li W - Search Results

1

Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas.

Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, Jen J, Testa JR. Pei J, et al. Among authors: li w. Genes Chromosomes Cancer. 2001 Jul;31(3):282-7. doi: 10.1002/gcc.1145. Genes Chromosomes Cancer. 2001. PMID: 11391799

2

Primary malignant tumors of the trachea. A radiologic and clinical study.

Li W, Ellerbroek NA, Libshitz HI. Li W, et al. Cancer. 1990 Sep 1;66(5):894-9. doi: 10.1002/1097-0142(19900901)66:5<894::aid-cncr2820660514>3.0.co;2-w. Cancer. 1990. PMID: 2386916

3

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK. Weiner LM, et al. Among authors: li ws. Cancer Res. 1995 Oct 15;55(20):4586-93. Cancer Res. 1995. PMID: 7553634 Clinical Trial.

4

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Weiner LM, et al. Among authors: li w. Cancer Res. 1994 Aug 1;54(15):4084-90. Cancer Res. 1994. PMID: 8033141 Clinical Trial.

5

Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.

Sun SY, Li W, Yue P, Lippman SM, Hong WK, Lotan R. Sun SY, et al. Among authors: li w. Cancer Res. 1999 May 15;59(10):2493-8. Cancer Res. 1999. PMID: 10344763

6

RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Zhao X, Ponomaryov T, Ornell KJ, Zhou P, Dabral SK, Pak E, Li W, Atwood SX, Whitson RJ, Chang AL, Li J, Oro AE, Chan JA, Kelleher JF, Segal RA. Zhao X, et al. Among authors: li j, li w. Cancer Res. 2015 Sep 1;75(17):3623-35. doi: 10.1158/0008-5472.CAN-14-2999-T. Epub 2015 Jun 30. Cancer Res. 2015. PMID: 26130651 Free PMC article.

7

PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer.

Wang Z, Dong H, Li W, Han F, Zhao L. Wang Z, et al. Among authors: li w. J Cancer. 2023 Apr 17;14(6):1049-1061. doi: 10.7150/jca.81430. eCollection 2023. J Cancer. 2023. PMID: 37151397 Free PMC article.

8

A nomogram for the prediction of the survival of patients with advanced non-small cell lung cancer and interstitial lung disease.

Xiu W, Zheng J, Zhou Y, Du H, Li J, Li W, Zhou F, Zhou C, Wu F. Xiu W, et al. Among authors: li j, li w. Cancer Med. 2023 May;12(10):11375-11384. doi: 10.1002/cam4.5852. Epub 2023 Mar 31. Cancer Med. 2023. PMID: 36999934 Free PMC article.

9

Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis.

Qin Y, Liu Y, Xiang X, Long X, Chen Z, Huang X, Yang J, Li W. Qin Y, et al. Among authors: li w. Mol Cancer. 2023 Mar 24;22(1):59. doi: 10.1186/s12943-023-01752-8. Mol Cancer. 2023. PMID: 36959665 Free PMC article.

10

Genomic variants in Fas-mediated apoptosis pathway predict a poor response to Platinum-based Chemotherapy for Chinese Gastric Cancer Patients.

Zhao T, Li W, Chen J, Qin W. Zhao T, et al. Among authors: li w. J Cancer. 2021 Jan 1;12(3):849-859. doi: 10.7150/jca.48120. eCollection 2021. J Cancer. 2021. PMID: 33403042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,573 results

Search Page

Filters